ESMO-Magnitude of Clinical Benefit Scale version 1.1.

导出原文传递

翻译打印收藏纠错

作者： N I,Cherny ^[1] ; U,Dafni ^[2] ; J,Bogaerts ^[3] ; N J,Latino ^[4] ; G,Pentheroudakis ^[5] ; J-Y,Douillard ^[4] ; J,Tabernero ^[6] ; C,Zielinski ^[7] ; M J,Piccart ^[8] ; E G E,de Vries ^[9]

作者单位： Cancer Pain and Palliative Medicine Service, Department of Medical Oncology, Shaare Zedek Medical Center, Jerusalem, Israel;. Electronic address: mcbs@esmo.org. ^[1] Laboratory of Biostatistics, School of Health Sciences, National and Kapodistrian University of Athens & Frontier Science Foundation-Hellas, Athens, Greece. ^[2] Methodology Direction, EORTC Headquarters, Brussels, Belgium. ^[3] ESMO Head Office, Lugano, Switzerland. ^[4] Medical Oncology Department, Ioannina University Hospital, Ioannina, Greece. ^[5] Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain. ^[6] Division of Oncology, Medical University Vienna, Vienna, Austria. ^[7] Jules Bordet Institute, Universite Libre de Bruxelles, Brussels, Belgium. ^[8] Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. ^[9]

关键词 European Society for Medical Oncology biostatistics magnitude of clinical benefit scale single arm studies

主题词生物统计学(Biostatistics);临床试验(主题)(Clinical Trials as Topic);人类(Humans);医学肿瘤学(Medical Oncology);肿瘤(Neoplasms);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1093/annonc/mdx310

PMID 28945867

发布时间 2022-04-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交